Literature DB >> 3959287

Pulmonary embolism as a cause of death. The changing mortality in hospitalized patients.

S E Dismuke, E H Wagner.   

Abstract

We studied the frequency and characteristics of death due to pulmonary embolism among all hospital and surgical patients in a university hospital from 1966 through 1980. Of 6,858 deaths, 3,412 autopsies were performed using a standardized and sensitive technique for pulmonary dissection. Our study showed that 6% of deceased patients (4.7% of surgical patients) had massive fatal embolism. Significant declines in embolism mortality were noted during this time period for hospital and surgical patients. The percentage of embolism cases among autopsies fell from 9.3% in the first five years to 3.8% in the last five years. Excluding patients receiving anticoagulants at the time of death, these percentages fell from 8.8% to 2.7%. The estimated hospital mortality rate for embolism fell during the same years from 0.37% of hospital discharges to 0.13%. During the years studied, the use of anticoagulants among all adult patients at the hospital increased from 4% of patients to nearly 12.3%. This and other evidence suggest the possibility that both the incidence rate and the case-fatality rate for pulmonary embolism have decreased in the hospital population we studied.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3959287

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  26 in total

1.  Pharmacological thromboembolic prophylaxis in a medical ward: room for improvement.

Authors:  Drahomir Aujesky; Emmanuèle Guignard; André Pannatier; Jacques Cornuz
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

Review 2.  Update in hospital medicine for the general internist 2010-2011.

Authors:  Romsai T Boonyasai; Daniel I Steinberg; Anneliese M Schleyer; Michelle M Mourad; Brian J Harte; Bradley A Sharpe
Journal:  J Gen Intern Med       Date:  2011-09-20       Impact factor: 5.128

3.  Prescription of enoxaparin is associated with decreasing pulmonary embolism mortality rate in Germany.

Authors:  Carolin Pütter; Olga von Beckerath; Hanna Maria Sobik; Holger Reinecke; Jürgen Stausberg; Knut Kröger
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

4.  Incidence rate of pulmonary embolism in Germany: data from the federal statistical office.

Authors:  K Kröger; Ch Moerchel; Th Moysidis; F Santosa
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

Review 5.  Venous thromboembolism: epidemiology, diagnosis, prevention.

Authors:  D M Becker
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

6.  Inhospital mortality among clinical and surgical inpatients recently diagnosed with venous thromboembolic disease.

Authors:  María Lourdes Posadas-Martínez; Fernando Javier Vázquez; María Florencia Grande-Ratti; Fernán González Bernaldo de Quirós; Diego Hernán Giunta
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

7.  The autopsy and diagnosis of pulmonary thrombo-embolism.

Authors:  Milton J Micallef
Journal:  Forensic Sci Med Pathol       Date:  2018-02-05       Impact factor: 2.007

Review 8.  Venous thromboembolism prophylaxis.

Authors:  Jonathan Laryea; Bradley Champagne
Journal:  Clin Colon Rectal Surg       Date:  2013-09

9.  Multicentre hospital drug utilization study on the prophylaxis of venous thromboembolism. The Venous Thromboembolism Study Group of the Spanish Society of Clinical Pharmacology.

Authors:  J A Vallès; A Vallano; F Torres; J M Arnau; J R Laporte
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

10.  Aggressive management of pulmonary embolism.

Authors:  Nael Saad
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.